Cargando…
A CRISPR/Cas12a-responsive dual-aptamer DNA network for specific capture and controllable release of circulating tumor cells
The separation and detection of circulating tumor cells (CTCs) have a significant impact on clinical diagnosis and treatment by providing a predictive diagnosis of primary tumors and tumor metastasis. But the responsive release and downstream analysis of live CTCs will provide more valuable informat...
Autores principales: | Wang, Dong-Xia, Wang, Jing, Wang, Ya-Xin, Ma, Jia-Yi, Liu, Bo, Tang, An-Na, Kong, De-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473531/ https://www.ncbi.nlm.nih.gov/pubmed/36277631 http://dx.doi.org/10.1039/d2sc03374g |
Ejemplares similares
-
MnO(2) nanosheets as a carrier and accelerator for improved live-cell biosensing application of CRISPR/Cas12a
por: Wang, Dong-Xia, et al.
Publicado: (2022) -
Photoresponsive immunomagnetic nanocarrier for capture and release of rare circulating tumor cells
por: Lv, Song-Wei, et al.
Publicado: (2015) -
Bioinspired DNA Nanointerface with Anisotropic Aptamers for Accurate Capture of Circulating Tumor Cells
por: Qin, Weiwei, et al.
Publicado: (2020) -
PAM-less conditional DNA substrates leverage trans-cleavage of CRISPR-Cas12a for versatile live-cell biosensing
por: Chen, Siyu, et al.
Publicado: (2022) -
Live-cell RNA imaging using the CRISPR-dCas13 system with modified sgRNAs appended with fluorescent RNA aptamers
por: Tang, Heng, et al.
Publicado: (2022)